Scholarlink

Background <p>Weight loss and energy restriction are potential strategies for reducing cancer risk, particularly if they reduce ectopic body fat and improve insulin resistance. This randomised study compared the effects of intermittent energy restriction [IER] to continuous energy restriction [CER] on hepatic, pancreatic and intramuscular fat, and insulin resistance.</p> Method <p>Premenopausal women with obesity [<i>n</i> = 28] were randomised to 8 weeks of 25% energy restriction: IER [2 days/week 600&#xa0;kcal/2511kj and 5 days/week Mediterranean diet] versus CER [7 days/week Mediterranean diet]. Changes in body weight, hepatic, pancreatic and calf intramuscular fat fractions [magnetic resonance spectroscopy] and insulin resistance [HOMA and oral glucose tolerance test], body fat and fat free mass [bioelectrical impedance], resting metabolic rate [RMR, indirect calorimetry] and lipids (total, LDL, HDL cholesterol and tryglycerides) were assessed during the energy restricted and normal eating days of IER compared to CER.</p> Results <p>9 IER and 11 CER participants completed the trial. IER and CER had comparable reductions in body weight mean [SD]: IER − 6.7[1.4] kg CER − 6.2[2.9] kg, and reductions in hepatic fat fraction mean [SD]: IER − 74.1[22.0]% CER − 51.4[34.8]%, pancreatic fat fraction mean [SD]: IER − 41.1[35.4]% CER − 30.8[25.4]% and calf intramuscular fat fraction mean [SD]: IER − 8.9[27.4]% CER − 2.3[24.1]%. Fasting measures of insulin resistance [HOMA IR, HOMA-β and fasting insulin] reduced in the CER group and with IER when assessed immediately after the two low energy days but were not maintained during normal eating days. There were no changes in 2-hour glucose in either group. The IER and CER groups had comparable reductions in FFM IER − 1.2[1.4] kg CER − 1.2[1.0] kg and RMR IER − 380[594] kj CER − 594[670] kj. Both groups had reductions in total and HDL cholesterol and triglyceride and maintained LDL.</p> Conclusions <p>IER and CER have comparable reductions in weight and ectopic fat stores, fat free mass and RMR and lipids. The clinical significance of the failure to maintain beneficial insulin sensitivity across the week with IER is not known and requires further study.</p> Trial registration <p>ISRCTN 10,803,394 Registration date 12/01/2015.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A randomised controlled trial of short-term Intermittent Energy Restriction [IER] versus Continuous Energy Restriction [CER] on body fat stores and measures of insulin resistance in women with obesity at increased risk of breast cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月27日

查看全文
  • Michelle Harvie,
  • Pete Coe,
  • Claire Higham,
  • Nina Peach,
  • Anthony Howell,
  • D. Gareth Evans,
  • Stephen Williams,
  • Kath Sellers,
  • Lee Malcomson,
  • Mary Pegington,
  • Andrew G. Renehan

摘要

Background

Weight loss and energy restriction are potential strategies for reducing cancer risk, particularly if they reduce ectopic body fat and improve insulin resistance. This randomised study compared the effects of intermittent energy restriction [IER] to continuous energy restriction [CER] on hepatic, pancreatic and intramuscular fat, and insulin resistance.

Method

Premenopausal women with obesity [n = 28] were randomised to 8 weeks of 25% energy restriction: IER [2 days/week 600 kcal/2511kj and 5 days/week Mediterranean diet] versus CER [7 days/week Mediterranean diet]. Changes in body weight, hepatic, pancreatic and calf intramuscular fat fractions [magnetic resonance spectroscopy] and insulin resistance [HOMA and oral glucose tolerance test], body fat and fat free mass [bioelectrical impedance], resting metabolic rate [RMR, indirect calorimetry] and lipids (total, LDL, HDL cholesterol and tryglycerides) were assessed during the energy restricted and normal eating days of IER compared to CER.

Results

9 IER and 11 CER participants completed the trial. IER and CER had comparable reductions in body weight mean [SD]: IER − 6.7[1.4] kg CER − 6.2[2.9] kg, and reductions in hepatic fat fraction mean [SD]: IER − 74.1[22.0]% CER − 51.4[34.8]%, pancreatic fat fraction mean [SD]: IER − 41.1[35.4]% CER − 30.8[25.4]% and calf intramuscular fat fraction mean [SD]: IER − 8.9[27.4]% CER − 2.3[24.1]%. Fasting measures of insulin resistance [HOMA IR, HOMA-β and fasting insulin] reduced in the CER group and with IER when assessed immediately after the two low energy days but were not maintained during normal eating days. There were no changes in 2-hour glucose in either group. The IER and CER groups had comparable reductions in FFM IER − 1.2[1.4] kg CER − 1.2[1.0] kg and RMR IER − 380[594] kj CER − 594[670] kj. Both groups had reductions in total and HDL cholesterol and triglyceride and maintained LDL.

Conclusions

IER and CER have comparable reductions in weight and ectopic fat stores, fat free mass and RMR and lipids. The clinical significance of the failure to maintain beneficial insulin sensitivity across the week with IER is not known and requires further study.

Trial registration

ISRCTN 10,803,394 Registration date 12/01/2015.